Axsome Therapeutics, Inc. (AXSM)
NASDAQ·Healthcare·Biotechnology
$143.68
+1.05%
Mkt Cap $8.18B
Analyst Ratings
Buy
26
Hold
3
Sell
0
Price Target (79 analysts)
$282.53
Range $246.00 – $380.00
Implied Upside
+96.6%
Consensus $282.53 vs current $143.68
NASDAQ·Healthcare·Biotechnology
$143.68
+1.05%
Mkt Cap $8.18B
Buy
26
Hold
3
Sell
0
Price Target (79 analysts)
$282.53
Range $246.00 – $380.00
+96.6%
Consensus $282.53 vs current $143.68